SCHEMBL13507916

SCHEMBL13507916

Oc1cc(OCc2ccccc2)c2c(c1)O[C@@H](c1ccc(O)c(O)c1)[C@H](O)C2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.65
▸ BACE1 P56817 6/20 0.65
▸ HSD17B10 Q99714 5/20 0.65
▸ ALDH1A1 P00352 4/20 0.65
▸ MAPT P10636 4/20 0.65
▸ ALOX15 P16050 4/20 0.65
▸ SNCA P37840 4/20 0.65
▸ GAA P10253 3/20 0.65
▸ MEN1 O00255 3/20 0.65
▸ KMT2A Q03164 3/20 0.65
▸ APEX1 P27695 3/20 0.65
▸ RECQL P46063 3/20 0.65
▸ CYP3A4 P08684 3/20 0.65
▸ PTGS1 P23219 3/20 0.65
▸ PKM P14618 2/20 0.65
▸ ALPL P05186 2/20 0.65
▸ POLB P06746 2/20 0.65
▸ MAPK1 P28482 2/20 0.65
▸ PTGS2 P35354 2/20 0.65
▸ HPGD P15428 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31161060 0.92 KDM4E (0.57) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL31160643 0.92 KDM4E (0.57) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL17358243 0.91 KDM4E (0.56) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL16019846 0.87 BACE1 (0.65) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL13508839 0.84 KDM4E (0.64) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL19743932 0.83 KDM4E (0.57) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL19743930 0.83 KDM4E (0.57) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL15220850 0.83 KDM4E (0.73) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL862191 0.83 KDM4E (0.73) KDM4EBACE1HSD17B10ALDH1A1MAPT
SCHEMBL13099978 0.83 KDM4E (0.73) KDM4EBACE1HSD17B10ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048920-A1 Preparation of (+)-Catechin, (-)-Epicatechin, (-)-Catechin, and (+)-Epicatechin and Their 5,7,3',4'-Tetra-O-Benzyl Analogues MARS, INCORPORATED (US) 2010-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048920-A1 Preparation of (+)-Catechin, (-)-Epicatechin, (-)-Catechin, and (+)-Epicatechin and Their 5,7,3',4'-Tetra-O-Benzyl Analogues HAAO, TES, HPD KDM4E 263/4885BACE1 3294/4885HSD17B10 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback